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Introduction
Tetrazoles are Nitrogen-rich five-member heterocycles having carbon and four nitrogen atoms arranged in a planar ring [1, 2] . Tetrazoles serve as non-classical isosteres of carboxylic acids owing to their close pK a values, physiological pH and a maximum nitrogen content of any heterocycles. The nitrogen-rich conjugated system confers tetrazoles with both donor and acceptor electronic properties [3] . The planar structure stabilizes negative charge by delocalization which is considered favorable for the receptor-ligand interaction. Tetrazolate anions are more lipophilic than carboxylates, which benefits the passage of drug molecules through cell membranes. Furthermore, tetrazoles are resistant to metabolic degradation pathways thus possess a longer duration of action [4] .
Tetrazoles and their heterocyclic analogues are termed as important pharmacophores in medicinal chemistry owing to their unique structure and favorable pharmacokinetic profile. Their pharmacological profile includes antihypertensive, antianalgesic, anti-ulcer and anti-allergic activities [5, 6, 7, 8, 9] . Tetrazoles based heterocycles have wide synthetic utility and serve as a precursor for the synthesis of potent heterocycles including propellants, explosives and pharmaceuticals [10, 11] . Heterocyclic analogues of tetrazoles serve as the first approved treatment for the partial agonist of dopamine D2 receptors [12, 13] . Tetrazoles based heterocycles serve as potent anticancer and antimicrobial agents [14] . Jack man et al. reports the potent cytotoxicity and growth inhibitory activities of tetrazoles containing drugs.
Tetrazoles based drugs have incomplete overlapping spectrum of antitumor activity and toxicity profile compared with tomudex and possibly other Thymidylate synthase inhibitors currently being studied clinically [15] . Leishmaniasis is a zoonosis that is transmitted between vertebrates and humans through sandfly. Literature survey reveals tetrazoles based heterocycles as potent antileishmanial agents. In this context, Pyrazolyl based tetrazoles are reported to be effective antileishmanial and cytotoxicity agents [16] . Similarly Faiões et al. reports the synthesis, antileishmanial potential and oral bioavailability of 5-[5-amino-1-(4 0 -methoxyphenyl)1H-pyrazole-4-yl]1H-tetrazole using a rational drug design approach [17] . Recently Viviane et al. reported the antileishmanial potential of arylpyrazole based tetrazoles. The synthesized arylpyrazole based tetrazoles displayed potent and innovative antileishmanial response [18] .
Thus keeping in view the exciting pharmacological profile of tetrazoles and their heterocyclic analogues, herein we report the facile synthesis and characterization of three differently substituted tetrazole derivatives (2, 4, 6) from commercially available substituted aromatic amines using sodium azide and triethyl orthoformate. The synthesis proceeds at reflux temperatures in the presence of glacial acetic acid. Upon successful completion of the reaction, crystals of the synthesized tetrazole derivatives (2, 4, 6) were grown from their supersaturated solutions and were characterized using single crystal XRD. The synthesized tetrazole derivatives (2, 4, 6) were tested for their cytotoxic and antileishmanial potential. Computational molecular docking studies were carried out to study the binding mode of the synthesized tetrazole derivatives (2, 4, 6).
2. Results and discussion 2.1. Synthesis of (2, 4, 6) Tetrazoles are nitrogen-rich heterocycles which display wide and potent spectrum of biological activities. The best known method for the synthesis of Tetrazoles is by treating sodium azide and triethyl orthoformate with aromatic amines in glacial acetic acid as shown in Fig. 1 [19] . Using this synthetic methodology, three different tetrazole derivatives (2, 4, 6) were successfully synthesized in higher yields. However, to the best of our knowledge, the synthesized tetrazole derivatives (4, 6) were found to be reported by Alexender et al. and Zhao et al respectively as clearly evident from the reference [20, 21] . 2.2. X-ray crystal structure description for the synthesized tetrazole derivatives (2, 4, 6) 2.2.1. X-ray crystal structure description for the tetrazole derivative (2)$H 2 O
The molecular structure of (2) (Fig. 2 ) is related to that of 2-(1H-tetrazol-1-yl)benzoic acid [21] . (2) shows the benzoic acid moiety co-planar with the aromatic ring plane, the relevant torsion angle is O2-C7-C5-C40.01 (19) , but the tetrazole ring is twisted relative to the C 6 ring plane, the torsion angle N2-N1-C1-C2 measures 25.95 (19) . Other relevant geometries are N1-N2 The crystal packing (Fig. 3) Tables 2 and 3 respectively. The tetrazole derivatives (2, 4) are reported as mentioned in references [20, 21] (see Fig. 5 ).
Biological activities of the synthesized tetrazole derivatives (2, 4, 6)
In vitro cytotoxicity and antileishmanial activities were performed in favor of the synthesized tetrazole derivatives (2, 4, 6) . Human red blood cells (Human red blood cells, approved by the review committee of the Biotechnology Department, Quaid-iAzam University, Islamabad, Pakistan, on February 7, 2014 ; the subjects also provided informed consent) were selected to perform cytotoxicity of the synthesized tetrazole derivative (2, 4, 6) . The release of hemoglobin from red blood cells determined the cytotoxicity of (2, 4, 6), measured using Uv-visible spectroscopy.
The extent of hemolysis was compared to that produced by Triton X-100 as a control and was found to be significantly less for the tested tetrazole derivatives (2, 4, 6) . The cytotoxicity data in terms of their LD 50 values is given below in Table 4 . Based on this data, it was found that the tested tetrazole derivatives (2, 4, 6) are biocompatible.
The ability of tetrazole derivatives (2, 4, 6) to act an antileishmanial agents against the promastigotes of Leishmania tropica was assayed using Glucantime as a positive and DMSO as a negative control. Glucantime is a drug used in treatment of cutaneous leishmaniasis. The antileishmanial data in terms of their IC 50 values are given below in Table 4 . The results reveal that the tested tetrazole derivatives (2, 4, 6) act as an inhibitor of this genus of trypanosomes. It was shown to have maximum antileishmanial activity compared to an IC 50 value of 7.44 mg/ml for the standard drug (Glucantime) [22] . 
Molecular docking study
The tested tetrazole derivatives (2, 4, 6) were further investigated for their binding mode by performing molecular docking study. The result of the docking computation for the tetrazole derivative (2, 4, 6) are given below.
Results and discussion of docking computation of (2)
A theoretical docking study, for evaluation of ligand as an inhibitor of trypanothione reductase a validated drug target enzyme of the Leishmania parasite was conducted. 
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The enzyme trypanothione reductase (TryR) is involved in the redox metabolism of the leishmania parasite, and inhibition of TryR can potentially disturb the redox balance of the parasite leading to death of the parasite [23] . The synthesized tetrazole derivative (2) was computationally docked into the pocket of trypanothione reductase (TryR) enzyme, required for redox balance of the parasite. Glide docking module, offered by Schrodinger program was used to carry out the molecular docking of synthesized molecule on protein [24] . The compound under analysis showed satisfactory docking with acceptable statistics inside the active site of TryR. The enzyme (TryR) is a dimer and chain A was selected for the docking studies. Docking analysis of the ligand with TryR protein enabled us to identify specific residues which constructed the active site. Following residues, Lue10, Gly11, Ala12 Gly13, Ser14, Gly15, Gly16, Val34, Asp35, Val36, Ala46, Ala47, Gly49, Gly50, Thr51, Cys52, Gly125, Phe126, Gl127, Ala159, Thr160, Ser162, Arg290, Ala293, Leu294, Ile325, Gly326, Asp327, Val328, Ala338, Met333, Leu334, Thr335, and Ala338, are found surrounding docked poses of the ligand. These residues can possibly play an important functional roles in enzyme activities. Therefore, interaction of the ligand with these residues could influence the structure of the active site, consequently leading to inhibition of the activities of the enzyme TryR.
The detailed analysis of the binding mode of the ligand with TryR receptor revealed that the ligand stabilized itself inside the active site gorge through copious interactions with the atoms of the key residues of receptor. represents the docked conformation of ligand inside the pockte of TyrR in two 
Results and discussion of docking computation of (4)
In order to investigate the potential antileishmanial properties of the tetrazole derivative (4), theoretical docking study was conducted on TryR and the compound. Trypanothione reductase (TryR) is involved in the redox metabolism of the leishmanial parasite, and inhibition of TryR could potentially disrupt the redox balance of the parasite leading to the parasite death [22] . The synthesized tetrazole derivative (4) was computationally docked into the pocket of trypanothione reductase (TryR) studies. Docking analysis of the ligand with TryR protein enabled us to identify specific residues which constructed the active site. Following residues are found surrounding docked poses of the ligand, Lue10, Gly11, Ala12Gly13, Ser14, Gly15, Gly16, Val34, Asp35, Val36, Ala46, Ala47, Gly49, Gly50, Thr51, Cys52, Gly125, Phe126, Gl127, Ala159, Thr160, Ser162, Arg290, Ala293, Leu294, Ile325, Gly326, Asp327, Val328, Ala338, Met333, Leu334, Thr335, and Ala338. These residues can possibly play important functional roles in enzyme activities.
Therefore, interaction of the ligand with these residues could influence the structure of the active site, consequently leading to the inhibition of the activities of the enzyme TryR.
The detailed analysis of the binding mode of the ligand with TryR receptor revealed that the ligand stabilized itself inside the active site gorge by copious interactions with the atoms of the key residues of receptor TryR. Tetrazole ring of the ligand formed p-p stacking with phenyl ring of Phe182 (Fig. 8) , similarly, phenyl ring of ligand also played important role in binding the ligand inside the pocket through (Fig. 8) . Moreover, compound was found to interact favorably with protein with a very good docking and Glide score of À6.217 kcal/mol.
Results and discussion of docking computation of (6)
A theoretical docking study was conducted in order to investigate the potential antileishmanial properties of the tetrazole derivative (6) against TryR. Trypanothione reductase (TryR) is involved in the redox metabolism of the leishmanial parasite, and inhibition of TryR could potentially disrupt the redox balance of the parasite leading to death of the parasite [22] . The tetrazole derivative (6) was computationally docked into the pocket of trypanothione reductase (TryR) enzyme, required for redox balance of the parasite. Glide docking module, offered by Schrodinger program [23] was used to carry out the molecular docking of synthesized molecule on protein.
The compound under analysis showed acceptable docking with satisfactory statistics inside the active site of TryR. The enzyme (TryR) is a dimer consisting of two active sites and the active site from chain A was selected for the docking studies. Docking analysis of the ligand with Try protein enabled us to identify specific residues which constructed the active site. Following residues, Lue10, Gly11, Ala12 Gly13, Ser14, Gly15, Gly16, Val34, Asp35, Val36, Ala46, Ala47, Gly49, Gly50, Thr51, Cys52, Gly125, Phe126, Gl127, Ala159, Thr160, Ser162, Arg290, Ala293, Leu294, Ile325, Gly326, Asp327, Val328, Ala338, Met333, Leu334, Thr335, and Ala338 are found surrounding docked poses of the ligand. These residues can play important functional roles in enzyme activities. Therefore, interaction of the ligand with these residues could possibly disrupt the function of the enzyme, consequently leading to inhibition of the activities of the enzyme TryR. 
Structure activity relationship (SAR)
The efficient delocalization of negative charge over tetrazole rings lead to a favorable interactions thereby help to increase the efficacy of tetrazole based drugs. Based on these observations, the present research work presents the cytotoxicity and antileishmanial evaluation of tetrazole derivatives (2, 4, 6 ). The tested tetrazole derivatives (2, 4, 6), were found to be biocompatible with respect to their cytotoxicity evaluation on human red blood cells (52.89, 17.28, 49.33 mg/ml). Among the tested tetrazole derivatives (2, 4, 6), the derivative (2) presented interesting antileishmanial activity against the promastigotes stage of Leishmania tropica (IC 50 ¼ 0.166 mg/ml) as given above in Table 1 . The tested tetrazole derivatives (2, 4) are isomeric in nature and differ only in the position of COOH group on the phenyl ring. In (2) when the hydrophilic COOH is at meta position is found to be most potent while compound (4) having the same group at ortho position is shows intermediate activities in both activities. On the other hand, in (6) in which the COOH is not a part of aromatic ring at all, rather attached to an aliphatic carbon is least active. This has been explained by docking studies.
The cytotoxicity (LD 50 ) and the antileishmanial activity (IC 50 ) of the tested derivatives were compared to assess the corresponding selectivity index (SI ¼ LD 50 /IC 50 ).
Among the tested derivatives, the tetrazole derivative (2) presented greater selectivity index for promastigotes stage of Leishmania tropica and least for tetrazole derivatives (4, 6). Structure activity relationship suggests the effect of the electron withdrawing carboxyl group on the tetrazole derivatives. The carboxyl group at para position of tetrazole derivative (2) enhances the antileishmanial activity against promastigotes of Leishmania tropica.
Experimental

Materials and method
All of the reagents and solvents required were purchased from Sigma-Aldrich and were used without any further purification. Glassware for performing chemical reaction performed were dried in an oven at 140 C for minimum of 6 hours prior to use.
1 H and 13 C nuclear magnetic resonance (NMR) spectra were recorded using DMSO- Crystals of the synthesized compound were grown by slow evaporation of ethanol at room temperature.
Procedure for the synthesis of tetrazole derivatives (2, 4, 6)
The tetrazole derivatives (2, 4, 6) were synthesized according to the literature reported method but with minor modifications. In a typical experiment, glacial acetic acid (15 ml) was added to a suspension of amino benzoic acids (10 mmol) and sodium azide (10 mmol) in triethyl orthoformate (20 mmol) with constant stirring at 400 rpm. The reaction mixture was than stirred at 150 C on an oil bath for almost 10 hours. Thin layer chromatography was constantly used to monitor the progress of the reaction. Upon completion of the reaction, a mixture of concentrated Hydrochloric acid (37%) and Water (25 ml) was poured in the flask till solid precipitates were formed. The solid precipitates formed, were separated by filtration and dried in oven at 50 C. The synthesized tetrazole derivatives (2, 4, 6) were obtained in good to excellent yields (75%, 63%, 84%) respectively. The oven dried solid precipitates of the tetrazole derivatives (2, 4, 6) were efficiently purified by recrystallization technique.
Purification of the tetrazole derivatives (2, 4, 6)
Once the tetrazole derivatives (2, 4, 6) were successfully synthesized, the compounds (2, 4, 6) were purified using column chromatography (30% hexane: ethyl acetate) which yield the purified compounds as solid precipitates. The tetrazole derivatives (2, 4, 6) were further purified by recrystallization method from ethanol.
Briefly, the synthesized tetrazole derivatives obtained were dissolved in ethanol and supersaturated solutions of (2, 4, 6) were prepared at 50 C. The prepared supersaturated solution of (2, 4, 6) were placed in glass vials covered with a lid to evaporate ethanol slowly from the solution at room temperature. Crystals of (2, 4, 6) appeared gradually as the evaporation of ethanol started at room temperature [19] . The crystals obtained were separated from the mixture, dried and were analysed using single crystal XRD to confirm the structure of tetrazole derivatives (2, 4, 6) . The characterization data of the tetrazole derivatives including 1 H NMR, 13 CNMR, CHN analysis is provided below for each of the synthesized tetrazole derivatives (2, 4, 6).
3.4. Characterization data of the synthesized tetrazole derivatives (2, 4, 6) 3.4. [27] . Briefly, 180 mL fresh human red blood cells were washed three times at 3000 rpm with phosphate buffer solution (PBS). The suspensions of the blood cell were incubated with 20 mL of compound with different concentrations (1000, 500, and 250 mg) at 37 C for 3 hours. After incubation, the suspended cells were centrifuged at 6000 rpm for 10 minutes. Using Uv-visible spectrophotometry (T80, pg instruments), the released hemoglobin was assessed at 576 nm by taking the supernatant. Triton X-100 (0.1%) was taken as positive control and the red blood cell suspension in PBS without compound was used as a negative control. Percent hemolysis was calculated by this formula:
3.6.2. Antileishmanial activity anti-leishmanial activity, were determined by SPSS22 software.
%Hemolysis ¼ ðOD at 576 nm in the compound solution À OD at 576 nm in PBSÞ ðOD at 576 nm in 0:1% Triton X À 100 À OD at 576 nm in PBSÞ Â 100
Molecular docking method
The crystal structure of the protein, was obtained from RCSB (PDB ID: 2JK6) [29] and was used for modeling purposes. ProteinPrep wizard of the Schrodinger program [30] was used to prepare protein for docking studies. Since the receptor contains cognate ligand therefore a grid was generated for docking purposes by creating a box centroid at the cognate ligands of the TRyR. The ligand was drawn in Maestro workspace using the builder module [31] , hydrogens were added and ligand was saved in three dimensional geometry for further use. The ligand was prepared using the Ligprep module offered by Schrodinger program [32] , and was used for further molecular docking studies. The Glide standard precision (Glide-SP) module was used for docking simulations [24] .
Conclusions
The present paper describes in detail the synthesis, molecular structure and bio-assay of tetrazole derivatives (2, 4, 6) . The substituted tetrazole derivatives (2, 4, 6) were synthesized in good yields and their crystal structures were determined using single crystal X-ray diffraction analysis. The crystal structure diversities of the tetrazoles (2, 4, 6) and various interactions responsible for their crystal stability are depicted in detail. In addition, in vitro cytotoxic and antileishmanial activity of the tetrazole derivatives (2, 4, 6) was also evaluated. The better in vitro biocompatibility and antileishmanial activity of the tetrazole derivatives (2, 4, 6) could be a better choice for further evaluation as therapeutic agents against leishmaniasis upon comparison with the standard drug (Glucantime). Molecular docking studies of the compounds with the TryR macromolecule could provide the first hand evidence for binding of compounds in active site of TryR. Thus, the synthesized tetrazole derivatives (2, 4, 6) can be possible hit candidate which can be tested further against amastigote stage of parasite and then in an animal model of leishmaniasis.
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